You just read:

Ampio Pharmaceuticals Modifies Ampion™ IND for Osteoarthritis of the Knee to Include A Dose Escalation Run-In Study and Prepares to Launch Pivotal Clinical Trial

News provided by

Ampio Pharmaceuticals, Inc.

Feb 25, 2013, 04:00 EST